u/rekha_mwangi
Contributes reviews on supplier material. Based in Lagos.
member · joined 13 Apr 2025
Comments — page 4 of 5
comment on someone explain moderation to me like I have not read a paper in years in c/meta · 32 points · 1 year ago
Did anything else change in the same window?
comment on my TSH moved and I cannot work out whether API source is why in c/compounding · 26 points · 1 year ago
API source questions are on-topic and compounders dodging them is newsworthy
comment on my TSH moved and I cannot work out whether API source is why in c/compounding · 161 points · 1 year ago
The telehealth + compounding combo cost compounding plus 3% markup. Not cheap but covered by insurance depending on state.
comment on cagrilintide — my 24-week log, condensed into one table in c/cagrilintide · 8 points · 1 year ago
REDEFINE which arm?
comment on the disclosure thing finally clicked for me and I want to write it down in c/meta · 4 points · 1 year ago
comment on the baseline labs thing finally clicked for me and I want to write it down in c/bloodwork · -14 points · 1 year ago
I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.
comment on [Meta] proposal — a flair for 503A posts in c/compounding · 100 points · 2 years ago
the shortage list is temporary, it ends and compounding becomes illegal again
comment on my ApoB moved and I cannot work out whether 503A is why in c/compounding · 10 points · 2 years ago
no pharmacy referral codes, naming is fine, recruiting is not
comment on my ApoB moved and I cannot work out whether 503A is why in c/compounding · 46 points · 2 years ago
shortage list status is 503A, check the actual list
comment on three years of pentadecapeptide threads, summarised so you do not have to read them in c/bpc157 · 9 points · 2 years ago
Inter-lab variance on this kind of assay is routinely 1–2 points.
Disagree on that part. 93.7% and 99.3% on the same vial is normal.
comment on [Question] Sweden — has anyone got a straight answer on pentadecapeptide in c/bpc157 · 7 points · 2 years ago
comment on Spain: meta, and what it actually costs here in c/meta · 60 points · 2 years ago
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
comment on unpopular opinion: CagriSema is massively overrated in c/cagrilintide · 53 points · 2 years ago
Not convinced. The evidence does not support that reading.
comment on [Vendor] QST order #19 — Canada, 15 days, no drama, receipts inside in c/bloodwork · 25 points · 2 years ago
redact identifying details from lab PDFs before posting
comment on [Lab] SGN survo — VendorInvestigate came back 93.7% against a claimed 98.6% in c/compounding · 36 points · 2 years ago
API transparency is the question that separates good compounders from sketchy ones
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on [Lab] SGN survo — VendorInvestigate came back 93.7% against a claimed 98.6% in c/compounding · 105 points · 2 years ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on [Lab] SGN survo — VendorInvestigate came back 93.7% against a claimed 98.6% in c/compounding · 365 points · 2 years ago
the 503A/503B distinction is load-bearing, do not blur it
comment on [Lab] SGN survo — VendorInvestigate came back 93.7% against a claimed 98.6% in c/compounding · 95 points · 2 years ago
the 503A/503B distinction is load-bearing, do not blur it
comment on ranking: the version I wish someone had shown me in week 1 in c/meta · 39 points · 2 years ago
rule-change proposals need concrete wording
comment on ranking: the version I wish someone had shown me in week 1 in c/meta · 7 points · 2 years ago
This is correct. Modmail first.